Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
Function of chylomicrons, VLDLs, LDLs and HDLs
|
They carry important lipids, TGs and cholesterol.
|
|
Fasting LDL levels
|
With tons of previous CV issues - <70
Great - <100 Desirable <130 Borderline 130-159 Bad >160 |
|
Fasting HDL levels
|
Great >60
Desirable >50 Borderline 40-50 Bad <40 |
|
General cholesterol pathway
|
Cholesterol is brought into hepatocytes by carrying molecules (e.g. LDL) and degraded to bile acids. These bile acids then secreted into gut and stool. But body sees bile acids in lumen of gut and absorbs some back into hepatocytes.
|
|
Cholestyramine
|
A resin that is a bile acid sequestrant. Binds to them and inhibits enterhepatic reuptake of bile salts.
This increases fecal loss of bile acids, increase bile acid synthesis, increases cholesterol synth, increases LDL receptor expression on cell surf of hepatocytes. Given as a powder. |
|
SE of cholestyramine
|
Very bad gas, diarrhea, abs of fat-sol vitamins.
|
|
Effectiveness of cholestyramine
|
10-20% reduction of LDL
|
|
Nicotinic acid
|
This is the same as Vit B3/niacin (which is used to tx pellagra).
Decreased prod of VLDLs and LDLs, increase in LDL receptor in liver. Can reduce TGs and LDLs. |
|
SEs of nicotinic acid
|
Facial flushing which can be lessened with aspirin (at high doses).
Some pts also develop hepatitis (at sustained release formulations). ALMOST NEVER USED AS MONOTHERAPY. |
|
Gemfibrozil
|
Fibric acid derivative that probably inhibits lipolysis and decreases FA reuptake. Also inhibits hepatic secretion of VLDLs.
|
|
SEs of gemfibrozil
|
Elev of LFTs/mild hepatitis, myositis, GI distress.
Don't rx with statins bc of similar SEs. |
|
Lovastatin
|
Lactone that inhibits HMG-CoA reductase. This stops prod of cholesterol and up-regulates LDL receptors on hepatocytes. Also results in small increase in HDLs.
|
|
Lovastatin metabolism
|
CYP3A4.
So be careful of drugs that are metab by CYP3A4 bc this will compete with their metabolism. (e.g. cyclosporine which has a very narrow ther range) Also be careful with things that inhibit CYP3A4. |
|
Lovastatin SEs
|
Liver and muscle. Never combine with fibrate (muscle or liver) or niacin (hepatitis).
Avoid in pregnancy too. |
|
Atorvastatin
|
50-60% reduction (Lipitor)
|
|
Lovastatin effectiveness
|
35-40% reduction and intermediate cost
|
|
Simvastatin effectiveness
|
35-40% reduction and very low cost.
|
|
Ezetimibe
|
Blocks intestinal abs of cholesterol and phytosterols. Acts at brush border.
Reduces hepatic chol stores and increases blood clearance of cholesterol. This is usually in combo with a statin. |
|
Ezetimibe SEs
|
Caution in pts with hepatic or renal impairment.
HA and diarrhea can result. |
|
JUPITER trial
|
Giving rosuvastatin to pts with high CRP reduced CV events and mortality.
|
|
Causes of shock
|
Sepsis, hemorrhage, burn, acute MI, anaphylaxis
|
|
Heart failure
|
Reduction of CO (forward failure)
or increase in venous filling pressure (back failure) Accompanied with remodeling. |
|
Positive inotropic effects...
|
LV contractility usually.
|
|
Positive chronotropic effects...
|
HR usually at SA node
|
|
Positive dromotropy effects...
|
Conduction usually through the AV node.
|
|
Solution to low preload
|
Volume replacement.
|
|
Solution to bradycardia (either chronotropy or dromotropy)
|
Atropine (but this won't work in a pt who had a heart transplant bc vagus n. is no longer connected to the heart)
Isoproterenol Pacemaker |
|
Tachycardia/arrythmia
|
Cardioversion (paddles)
Antiarrythmics |
|
Short-term diminished inotropic state
|
Epinephrine
DA Dobutamine Amrinone calcium glucagon digoxin correct pH correct hypoxemia. |
|
NE
|
mainly effects alpha 1 so you get vasoconstriction. do not give this to ppl with contractility problems.
|
|
Epinephrine
|
Alpha 1, beta1, beta2. So it is good for anaphylaxis, increasing contractility.
|
|
Dobutamine
|
Similar to dopamine but more specific for beta1 compared to dopamine.
Increases contractility of the ventricles more than the SA node effects of stimulating tachycardia. This is good bc in the coronary care unit you don't really need tachycardia. |
|
Correcting peripheral vasoconstriction
|
(Captopril)
Enalpril Lisinopril Hydralazine Prazosin Carvedilol (partly an alpha1 blocker) Nitroglycerin Nitroprusside |
|
Correcting excessive, abnormal contractility (e.g. idiopathic hypertrophic subaortic stenosis)
|
Propanolol or verapamil
(these drugs relax the big heart muscle) |
|
Where are there beta receptors?
|
SA node, AV node, ventricles.
|
|
Dopamine
|
Low dose - DA receptors in mesentary and kidney to increase blood there.
Medium - Beta1 receptors; increases contractility and HR High - Stim alpha1 to produce vasoconstriction (bad for CHF) IV only. MAOIs intensify its effects. |
|
Amrinone
|
Inotropic and vasodilator. Mainly at peripheral arterioles.
IV admin. May cause arrythmias. Do not mix with furosemide. Good to use during diminished inotropic state. |
|
Vasodilators used to improve CHF
|
Lisinopril, hydralazine, prazosin, nitroprusside.
In general, pure vasodilators like hydralazine and nitroprusside don't improve pt survival. Remember BiDil for black pts. (hydralazine plus isosorbide dinitrate) |
|
Preload reducing agents
|
Diuretics.
|
|
Acute tx of heart failure
|
Inotropic support is ok acutely, but harmful long term.
And beta blockers make things worse short term, but help long term. |
|
Things that cause remodeling:
|
Beta stimulation
AT II Aldosterone. (want to interrupt these long-term) |
|
Tx of CHF long term
|
Carvedilol, sustained release metoprolol. Or ACE inh.
|
|
Blocking aldosterone can lead to...
|
hyperkalemia.
|